Tonix Pharmaceuticals Announces Exclusive Option And Research Collaboration With Kansas State University To Develop LNP-Free mRNA Vaccines
New Zinc Nanoparticle (ZNP) Technology Replaces the Lipid Nanoparticle (LNP) Technology Employed in Current mRNA COVID-19 Vaccines
ZNP Technology Expected to Improve mRNA Vaccine Temperature Stability